Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Terragene S.A. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

267 daysmedian FDA review time
742 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K242453Terragene® Bionova® Photon Process Challenge Device with uniTerragene S.A.2024-12-121150
K231383Terragene® Bionova® Self-Contained Biological Indicator (BT9Terragene S.A.2024-09-184950
DEN220042Terragene Bionova Photon Biological Indicator (BT225); TerraTerragene S.A.2024-07-127420
K232103Terragene® Chemdye® Multivariable Chemical Indicator (CD40),Terragene S.A.2024-04-052660
K221641Terragene® Bionova® Hyper Biological Indicator (BT98), TerraTerragene S.A.2023-02-282670
K200272Terragene ChemdyeTerragene S.A.2020-06-301470
K191021Terragene Bionova, Terragene Bionova, Terragene Integron, TeTerragene S.A.2019-09-131491
K163646Terragene Bionova(R) SCBI (BT220, BT221, BT222, BT223), TerrTerragene S.A.2017-11-023142

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda